Bio-Rad Laboratories, Inc.’s (BIO) share price has entered into oversold territory with a stochastic value of 18.37. The Zacks Consensus Estimate on the company’s earnings for 2010 has increased by 3 cents over the past week to $5.02 per share. Bio-Rad Laboratories is a Zacks #2 Rank (“Buy”) company.
“BIO” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research